Type 2 Diabetes Trial, Not Yet Recruiting NCT07560800 Sponsor: Oxford Brookes University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07560800
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been clinically diagnosed with Type 2 Diabetes.
  • People who are between 40 and 65 years of age.
  • People who are not currently being treated with insulin.
  • People whose diabetes medications have remained unchanged for at least 3 months.
  • People who are able to understand the study information and agree to take part.
  • People who are able to safely do light-to-moderate cycling exercise.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently using insulin or have used it recently.
  • People who use medications called organic nitrates (such as glyceryl trinitrate) or a class of drugs known as phosphodiesterase-5 inhibitors (such as sildenafil or tadalafil).
  • People who have taken antibiotic tablets or capsules within a specified period before the study, or who regularly use antiseptic or antibacterial mouthwash.
  • People who have taken certain supplements that may affect how the body processes nitric oxide within a defined period before the study (confirm with trial site for specifics).
  • People with unstable or significant heart or blood vessel disease.
  • People with uncontrolled high blood pressure, or any condition that makes exercise unsafe for them.
  • People with chronic kidney disease, a history of kidney stones, or other relevant kidney conditions.
  • People with neurological, musculoskeletal, or systemic conditions that could make safe participation difficult.
  • People with a known or suspected allergy or intolerance to beetroot, lemon, or any ingredient in the study products.
  • People who are pregnant or breastfeeding.
  • People who are unable to follow the preparation requirements of the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +447523113252

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Oxford Brookes University
Registry
ClinicalTrials.gov
Start date
2 April 2026
Est. completion
31 July 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Systolic Blood Pressure During Post-Exercise Recovery; Heart Rate Variability (RMSSD) During Post-Exercise Recovery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov